防风通圣散联合二甲双胍治疗肥胖型多囊卵巢综合征临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.75

基金项目:

杭州市科技计划引导项目(20211231Y152)


Clinical Study on Fangfeng Tongsheng Powder Combined with Metformin for Obese Polycystic Ovary Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察防风通圣散联合二甲双胍治疗肥胖型多囊卵巢综合征(PCOS) 的临床疗效。方法:采 用随机数字表法将140 例肥胖型PCOS 患者分为对照组、观察组各70 例。对照组采用二甲双胍治疗,观察组 采用防风通圣散联合二甲双胍治疗。比较2 组治疗前后痤疮严重程度评分、中医证候积分、体质量指 数(BMI)、卵巢体积、糖代谢指标、血脂代谢指标、性激素指标;比较2 组治疗1 个月、3 个月后基础体 温(BBT);比较2 组临床疗效及不良反应发生率。结果:研究期间,对照组剔除3 例,脱落4 例;观察组剔 除3 例,脱落4 例,2 组各完成研究63 例。观察组总有效率92.06%,高于对照组79.37%(P<0.05)。2 组治 疗后痤疮严重程度评分、中医证候积分、BMI、卵巢体积低于治疗前(P<0.05),且观察组治疗后上述指标低 于对照组(P<0.05)。2 组治疗后卵泡刺激素(FSH)、抗苗勒管激素(AMH)、雌二醇(E2)、黄体生成 素(LH)、孕酮(P)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)、甘油三酯(TG)、空腹血糖(FBG)、 空腹胰岛素(FINS) 水平及胰岛素抵抗指数(HOMA-IR) 均较治疗前降低(P<0.05),高密度脂蛋白胆固 醇(HDL-C) 升高(P<0.05);观察组治疗后性激素、糖代谢指标及LDL-C、TC、TG 水平低于对照组(P< 0.05),HDL-C 水平高于对照组(P<0.05)。2 组治疗3 个月后BBT 单相占比低于治疗1 个月后(P<0.05), BBT 偶有双相、BBT 双相占比高于治疗1 个月后(P<0.05),且观察组治疗3 个月后BBT 单相占比、BBT 偶 有双相占比低于对照组(P<0.05),BBT 双相占比高于对照组(P<0.05)。2 组不良反应发生率比较,差异无 统计学意义(P>0.05)。结论:防风通圣散联合二甲双胍治疗肥胖型PCOS 疗效确切,能降低患者体质量,改 善糖脂代谢功能,调节性激素水平,安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Fangfeng Tongsheng Powder combined with Metformin for obese polycystic ovary syndrome (PCOS). Methods: A total of 140 cases of patients with obese PCOS were divided into the control group and the observation group according to the random number table method, with 70 cases in each group. The control group was treated with Metformin, and the observation group was treated with Fangfeng Tongsheng Powder combined with Metformin. Before and after treatment,the severity scores of acne,traditional Chinese medicine (TCM) syndrome scores,body mass index (BMI),ovarian volume,glucose metabolism,lipid metabolism and sex hormone indexes were compared between the two groups. Basal body temperature (BBT) in the two groups was compared after 1 month and 3 months of treatment. The clinical effects and the incidence of adverse reactions were compared between the two groups. Results:During the study period,3 cases were removed and 4 cases dropped out in the control group; 3 cases were removed and 4 cases dropped out in the observation group; a total of 63 cases were completed in each group. The total effective rate was 92.06% in the observation group,higher than that of 79.37% in the control group (P<0.05). The severity scores of acne, TCM syndrome scores, BMI, and ovarian volume in the the two groups were lower than those before treatment (P<0.05),and the above indexes in the observation group were lower than those in the control group (P<0.05). After treatment,the levels of follicle stimulating hormone (FSH),anti-mullerian hormone (AMH), estradiol (E2), luteinizing hormone (LH), progesterone (P), low- density lipoprotein cholesterol (LDL-C),total cholesterol (TC),triglyceride (TG),fasting blood glucose (FBG),and fasting insulin (FINS), and Homeostatic Model Assessment of Insulin Resistance (HOMA- IR) in the two groups were decreased when compared with those before treatment (P<0.05), and the levels of high- density lipoprotein cholesterol (HDL- C) were increased (P<0.05). After treatment, the levels of sex hormone, glucose metabolism indexes,LDL-C,TC,and TG in the observation group were lower than those in the control group (P < 0.05) , and the level of HDL-C was higher than that in the control group (P < 0.05). After 3 months of treatment,the proportion of single-phase BBT in the two groups was lower than that after 1 months of treatment (P<0.05),and the proportions of occasional dual-phase BBT and dual-phase BBT were higher than those after 1 months of treatment (P<0.05); the proportion of single- phase BBT and occasional dual- phase BBT in the observation group was lower than that in the control group (P<0.05), and the proportions of dual-phase BBT were higher than those in the control group (P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Fangfeng Tongsheng Powder combined with Metformin has a definite curative effect in treating obese PCOS,which can reduce the body mass of patients,improve the function of glucose and lipid metabolism and regulate the levels of sex hormones,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

仲英华,毛芳,曹晓春.防风通圣散联合二甲双胍治疗肥胖型多囊卵巢综合征临床研究[J].新中医,2023,55(17):56-61

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-09-07
  • 出版日期:
文章二维码